# LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 P&L / Income Statement

- Company: LEMAITRE VASCULAR, INC. (LMAT)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001193125-26-333762
- Page: https://plicit.ai/financials/lmat/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/lmat-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 70,382,000 US dollars
- **Cost of sales**: 19,618,000 US dollars
- **Gross profit**: 50,764,000 US dollars
- **Total operating expenses**: 30,365,000 US dollars
- **Income from operations**: 20,399,000 US dollars
- **Other income (expense), net (calculated)**: 1,790,000 US dollars
- **Income before income taxes**: 22,189,000 US dollars
- **Provision for income taxes**: 5,139,000 US dollars
- **Net income**: 17,050,000 US dollars
- **UNITED STATES**: 38,250,000 US dollars
- **GERMANY**: 5,341,000 US dollars
- **CANADA**: 4,551,000 US dollars
- **UNITED KINGDOM**: 3,725,000 US dollars
- **Other countries**: 18,515,000 US dollars
- **General and administrative**: 11,110,000 US dollars
- **Research and development**: 4,847,000 US dollars
- **Sales and marketing**: 14,408,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.